Cyclerion Therapeutics (CYCN) EBIT (QoQ) (2018 - 2025)
Cyclerion Therapeutics (CYCN) EBIT (QoQ) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - |
| 10 | Cyclerion Therapeutics | 12.45 Mn | 9.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 39.83% |
| Jun 30, 2025 | -14.76% |
| Mar 31, 2025 | -390.24% |
| Dec 31, 2024 | 144.50% |
| Sep 30, 2024 | 18.50% |
| Jun 30, 2024 | 14.46% |
| Mar 31, 2024 | 9.86% |
| Dec 31, 2023 | 70.16% |
| Sep 30, 2023 | -222.52% |
| Jun 30, 2023 | 43.05% |
| Mar 31, 2023 | 26.49% |
| Dec 31, 2022 | 1.39% |
| Sep 30, 2022 | 66.37% |
| Jun 30, 2022 | -3.46% |
| Mar 31, 2022 | 9.44% |
| Dec 31, 2021 | -27.05% |
| Sep 30, 2021 | 30.24% |
| Jun 30, 2021 | -20.76% |
| Mar 31, 2021 | 30.32% |
| Dec 31, 2020 | 11.74% |